EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Docking-Based Evidence for the Potential of ImmunoDefender: A Novel Formulated Essential Oil Blend Incorporating Synergistic Antiviral Bioactive Compounds as Promising Mpro Inhibitors against SARS-CoV-2

Ayoub Ksouri iD, Anis Klouz, Balkiss Bouhaouala-Zahar iD, Fathi Moussa, Mounir Bezzarga

Molecules · 2023

DOI: 10.3390/molecules28114296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Ayoub Ksouri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire des Biomolécules, Venins et Applications Théranostiques, Institut Pasteur de Tunis, Université Tunis El Manar, 13 Place Pasteur, BP74, Tu…. Hauptthemen laut MEDLINE: COVID-19, Oils, Volatile. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BIODEX-SA company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Essential oils (Eos) have demonstrated antiviral activity, but their toxicity can hinder their use as therapeutic agents. Recently, some essential oil components have been used within safe levels of acceptable daily intake limits without causing toxicity. The “ImmunoDefender,” a novel antiviral compound made from a well-known mixture of essential oils, is considered highly effective in treating SARS-CoV-2 infections. The components and doses were chosen based on existing information about their structure and toxicity. Blocking the main protease (Mpro) of SARS-CoV-2 with high affinity and capacity is critical for inhibiting the virus’s pathogenesis and transmission. In silico studies were conducted to examine the molecular interactions between the main essential oil components in “ImmunoDefender” and SARS-CoV-2 Mpro. The screening results showed that six key components of ImmunoDefender formed stable complexes with Mpro via its active catalytic site with binding energies ranging from −8.75 to −10.30 kcal/mol, respectively for Cinnamtannin B1, Cinnamtannin B2, Pavetannin C1, Syzyginin B, Procyanidin C1, and Tenuifolin. Furthermore, three essential oil bioactive inhibitors, Cinnamtannin B1, Cinnamtannin B2, and Pavetannin C, had significant ability to bind to the allosteric site of the main protease with binding energies of −11.12, −10.74, and −10.79 kcal/mol; these results suggest that these essential oil bioactive compounds may play a role in preventing the attachment of the translated polyprotein to Mpro, inhibiting the virus’s pathogenesis and transmission. These components also had drug-like characteristics similar to approved and effective drugs, suggesting that further pre-clinical and clinical studies are needed to confirm the generated in silico outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Oils, VolatileHumansAntiviral AgentsMolecular Docking SimulationMolecular Dynamics SimulationPeptide HydrolasesProtease InhibitorsSARS-CoV-2Viral Nonstructural Proteins

Stichwörter der Autor:innen

ImmunoDefenderSARS-CoV-2active and allosteric sitesantiviralbioactive moleculesessential oils (Eos)main-protease

Substanzen

Antiviral AgentsOils, VolatilePeptide HydrolasesProtease InhibitorsViral Nonstructural Proteins

Autor:innen und Institutionen

  • Laboratoire des Biomolécules, Venins et Applications Théranostiques, Institut Pasteur de Tunis, Université Tunis El Manar, 13 Place Pasteur, BP74, Tunis 1002, Tunisia.
  • Faculté de Médecine de Tunis, Université Tunis El Manar, 15 Rue Djebel Lakhdhar, La Rabta, Tunis 1007, Tunisia.
  • Institute of Physical Chemistry, CNRS-UMR 8000, University Paris-Saclay, Rue Noetzlin, 91190 Gif-sur-Yvette, France.
  • Laboratoire de Modélisation Mathématique, Faculté des Sciences de Tunis, Université Tunis El Manar, Analyse Harmonique et Théorie du Potentiel, Campus Universitaire, Tunis 1068, Tunisia.
  • Institut Préparatoire aux Etudes d'Ingénieurs de Tunis, Université de Tunis, Tunis 1068, Tunisia.

ORCID-Profile: Ayoub Ksouri, Balkiss Bouhaouala-Zahar

Förderung

  • BIODEX-SA company

Zitieren

APA

Ksouri, A., Klouz, A., Bouhaouala-Zahar, B., Moussa, F., & Bezzarga, M. (2023). Docking-Based Evidence for the Potential of ImmunoDefender: A Novel Formulated Essential Oil Blend Incorporating Synergistic Antiviral Bioactive Compounds as Promising Mpro Inhibitors against SARS-CoV-2. Molecules. https://doi.org/10.3390/molecules28114296

Vancouver

Ksouri A, Klouz A, Bouhaouala-Zahar B, Moussa F, Bezzarga M. Docking-Based Evidence for the Potential of ImmunoDefender: A Novel Formulated Essential Oil Blend Incorporating Synergistic Antiviral Bioactive Compounds as Promising Mpro Inhibitors against SARS-CoV-2. Molecules. 2023. doi:10.3390/molecules28114296

BibTeX
@article{Ksouri2023,
  author = {Ksouri, Ayoub and Klouz, Anis and Bouhaouala-Zahar, Balkiss and Moussa, Fathi and Bezzarga, Mounir},
  title = {Docking-Based Evidence for the Potential of ImmunoDefender: A Novel Formulated Essential Oil Blend Incorporating Synergistic Antiviral Bioactive Compounds as Promising Mpro Inhibitors against SARS-CoV-2},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28114296}
}
Kostenlos starten →